Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00828516What this trial is testingUsing Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaWho this might be right forBreast CancerHead and Neck CancerLymphedema East and North Hertfordshire NHS Trust 56
Post-approval studies (Phase 4)Looking for participantsNCT07405086What this trial is testingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64
Not applicableStudy completedNCT04540588What this trial is testingRetreatment With Intratumoral Diffusing Alpha Radiation EmittersWho this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)Looking for participantsNCT06731933What this trial is testingImpact of COL7A1 Gene Therapy on SCC Recurrence in RDEB SkinWho this might be right forSquamous Cell Carcinoma Stanford University 16
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Not applicableActive Not RecruitingNCT05323253What this trial is testingAlpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell CarcinomaWho this might be right forRecurrent Squamous Cell Carcinoma Alpha Tau Medical LTD. 86
Testing effectiveness (Phase 2)Study completedNCT03284424What this trial is testingStudy of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)Who this might be right forSquamous Cell Carcinoma Merck Sharp & Dohme LLC 159
Testing effectiveness (Phase 2)Study completedNCT02964559What this trial is testingPembrolizumab in Patients With Locally Advanced or Metastatic Skin CancerWho this might be right forRecurrent Skin CarcinomaSkin Squamous Cell Carcinoma Emory University 11
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT04592484What this trial is testingA First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid TumorsWho this might be right forAdvanced Solid Tumor Codiak BioSciences 27
Testing effectiveness (Phase 2)Study completedNCT01198028What this trial is testingErlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell CarcinomaWho this might be right forMetastatic Skin Squamous Cell CarcinomaRecurrent Skin Squamous Cell Carcinoma M.D. Anderson Cancer Center 42
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Testing effectiveness (Phase 2)Study completedNCT00003565What this trial is testingDocetaxel in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 109
Large-scale testing (Phase 3)Looking for participantsNCT06589804What this trial is testingTesting the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentWho this might be right forMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more National Cancer Institute (NCI) 158
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41